Cargando…
Crosstalk between autophagy and metabolic regulation of (CAR) T cells: therapeutic implications
Despite chimeric antigen receptor (CAR) T cell therapy’s extraordinary success in subsets of B-cell lymphoma and leukemia, various barriers restrict its application in solid tumors. This has prompted investigating new approaches for producing CAR T cells with superior therapeutic potential. Emerging...
Autores principales: | Panahi Meymandi, Ahmad Reza, Akbari, Behnia, Soltantoyeh, Tahereh, Hadjati, Jamshid, Klionsky, Daniel J., Badie, Behnam, Mirzaei, Hamid Reza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10477670/ https://www.ncbi.nlm.nih.gov/pubmed/37675121 http://dx.doi.org/10.3389/fimmu.2023.1212695 |
Ejemplares similares
-
Genetic Modification of Cytokine Signaling to Enhance Efficacy of CAR T Cell Therapy in Solid Tumors
por: Ghahri-Saremi, Navid, et al.
Publicado: (2021) -
PGE2-EP2/EP4 signaling elicits mesoCAR T cell immunosuppression in pancreatic cancer
por: Akbari, Behnia, et al.
Publicado: (2023) -
The inhibitory receptors PD1, Tim3, and A2aR are highly expressed during mesoCAR T cell manufacturing in advanced human epithelial ovarian cancer
por: Akbari, Behnia, et al.
Publicado: (2023) -
Chimeric Antigen Receptor (CAR) T Cell Therapy for Metastatic Melanoma: Challenges and Road Ahead
por: Soltantoyeh, Tahereh, et al.
Publicado: (2021) -
Outsmarting trogocytosis to boost CAR NK/T cell therapy
por: Ramezani, Faezeh, et al.
Publicado: (2023)